144 related articles for article (PubMed ID: 1726208)
1. Cefpodoxime proxetil in the treatment of skin and soft tissue infections.
Tack KJ; Wilks NE; Semerdjian G; Frazier CH; Shirin K; Puopolo A; Crossland SG; Goffe BS; Millikan L
Drugs; 1991; 42 Suppl 3():51-6. PubMed ID: 1726208
[TBL] [Abstract][Full Text] [Related]
2. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
Fulton B; Perry CM
Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
[TBL] [Abstract][Full Text] [Related]
3. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
Geddes AM
Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206
[TBL] [Abstract][Full Text] [Related]
4. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.
Stevens DL; Pien F; Drehobl M
Diagn Microbiol Infect Dis; 1993 Feb; 16(2):123-9. PubMed ID: 8467623
[TBL] [Abstract][Full Text] [Related]
5. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections.
Cox CE; Graveline JF; Luongo JM
Drugs; 1991; 42 Suppl 3():41-50. PubMed ID: 1726207
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of cefpodoxime proxetil dry syrup for skin and soft tissue infections in the field of pediatrics].
Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Fujimoto T; Yokochi K; Yamashita F
Jpn J Antibiot; 1989 Jul; 42(7):1685-704. PubMed ID: 2681866
[TBL] [Abstract][Full Text] [Related]
7. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
Balfour JA; Benfield P
Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections].
Li JT; Hou J; Kao L
Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436
[TBL] [Abstract][Full Text] [Related]
9. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C
Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242
[TBL] [Abstract][Full Text] [Related]
10. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Frampton JE; Brogden RN; Langtry HD; Buckley MM
Drugs; 1992 Nov; 44(5):889-917. PubMed ID: 1280571
[TBL] [Abstract][Full Text] [Related]
11. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
MacLoughlin GJ; Barreto DG; de la Torre C; Pinetta EA; del Castillo F; Palma L
J Antimicrob Chemother; 1996 Mar; 37(3):565-73. PubMed ID: 9182113
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of infectious complications affecting the skin and soft tissues with cefpodoxime proxetil].
Vyhnánek F; Lochmann O
Epidemiol Mikrobiol Imunol; 1996 May; 45(2):68-70. PubMed ID: 8756403
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia.
Zuck P; Rio Y; Ichou F
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():71-7. PubMed ID: 2292534
[TBL] [Abstract][Full Text] [Related]
14. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
Safran C
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis.
Gehanno P; Depondt J; Barry B; Simonet M; Dewever H
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():87-91. PubMed ID: 2127269
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.
Periti P; Novelli A; Schildwachter G; Schmidt-Gayk H; Ryo Y; Zuck P
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():63-9. PubMed ID: 2292532
[TBL] [Abstract][Full Text] [Related]
17. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media.
Mendelman PM; Del Beccaro MA; McLinn SE; Todd WM
J Pediatr; 1992 Sep; 121(3):459-65. PubMed ID: 1517926
[TBL] [Abstract][Full Text] [Related]
18. A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults.
Phillips H; Van Hook CJ; Butler T; Todd WM
Chest; 1993 Nov; 104(5):1387-92. PubMed ID: 8222793
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials of cefpodoxime proxetil suspension in paediatrics.
Fujii R
Drugs; 1991; 42 Suppl 3():57-60. PubMed ID: 1726209
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
Asmar BI; Dajani AS; Del Beccaro MA; Mendelman PM
Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
